Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Marianna Ponzo
Observed names:
PONZO, MARIANNA,
Ponzo, Marianna
Institutions:
University of Zurich,
University Hospital Zurich
Observed institutions:
Mario Negri Institute for Pharmacological Research,
University of Zurich,
University Hospital Zurich,
University of Milano-Bicocca
ORCID:
0000-0002-0003-5524
Observed ORCID:
0000-0002-0003-5524
OpenAlex ID:
A5070420908
The Past, Present, and Future of Non-Viral CAR T Cells
2022
·
Alex Moretti
, Marianna Ponzo
, et al.
·
Frontiers in Immunology
·
180
PDF
Anti-CD117 CAR T cells incorporating a safety switch eradicate human acute myeloid leukemia and hematopoietic stem cells
2023
·
Chiara F. Magnani
, Renier Myburgh
, et al.
·
Molecular Therapy — Oncolytics
·
38
PDF
Quantitative determination of niraparib and olaparib tumor distribution by mass spectrometry imaging
2020
·
Lavinia Morosi
, Cristina Matteo
, et al.
·
International Journal of Biological Sciences
·
30
PDF
Combination of PPARγ Agonist Pioglitazone and Trabectedin Induce Adipocyte Differentiation to Overcome Trabectedin Resistance in Myxoid Liposarcomas
2019
·
Roberta Frapolli
, Ezia Bello
, et al.
·
Clinical Cancer Research
·
25
PDF
Acquisition of an immunosuppressive microenvironment after anti-CD19 CAR T-cell therapy is associated with T-cell dysfunction and resistance
2025
·
Marianna Ponzo
, Lorenzo Drufuca
, et al.
·
Journal for ImmunoTherapy of Cancer
·
18
PDF
Readily prepared biodegradable nanoparticles to formulate poorly water soluble drugs improving their pharmacological properties: The example of trabectedin
2018
·
Umberto Capasso Palmiero
, Lavinia Morosi
, et al.
·
Journal of Controlled Release
·
16
Mechanism of efficacy of trabectedin against myxoid liposarcoma entails detachment of the FUS-DDIT3 transcription factor from its DNA binding sites
2024
·
Ilaria Craparotta
, Laura Mannarino
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
9
PDF
Self‐Assembling PCL‐Based Nanoparticles as PTX Solubility Enhancer Excipients
2018
·
Umberto Capasso Palmiero
, Lavinia Morosi
, et al.
·
Macromolecular Bioscience
·
9
Co-editing of NKG2A and FAS increases long-term cytotoxic capacity and persistence of CAR NK cells
2026
·
Juliane Mietz
, Lukas Egli
, et al.
·
Molecular Therapy Oncology
·
4
Validated LC-MS/MS Assay for the Quantitative Determination of Fenretinide in Plasma and Tumor and Its Application in a Pharmacokinetic Study in Mice of a Novel Oral Nanoformulation of Fenretinide
2024
·
Cristina Matteo
, Isabella Orienti
, et al.
·
Pharmaceutics
·
4
PDF
Carcik-CD19 Cells Expand In Vivo Toward a CD8+ Memory Phenotype and Their Persistence Is Associated with a Longer Duration of Response
2022
·
Benedetta Rambaldi
, Stefania Galimberti
, et al.
·
Blood
·
2
Role of Microenvironment in Influencing the Activity of CD19 CAR T Cells in B-Cell Precursor Acute Lymphoblastic Leukemia (B-ALL)
2023
·
Marianna Ponzo
, Lorenzo Drufuca
, et al.
·
Blood
·
1
PDF
Data from Combination of PPARγ Agonist Pioglitazone and Trabectedin Induce Adipocyte Differentiation to Overcome Trabectedin Resistance in Myxoid Liposarcomas
2023
·
Roberta Frapolli
, Ezia Bello
, et al.
·
1
Correction: Combination of PPARγ Agonist Pioglitazone and Trabectedin Induce Adipocyte Differentiation to Overcome Trabectedin Resistance in Myxoid Liposarcomas
2020
·
Roberta Frapolli
, Ezia Bello
, et al.
·
Clinical Cancer Research
·
1
LILRB2 Promotes CAR T-cell Dysfunction and Represents a Therapeutic Target in Acute Myeloid Leukemia
2026
·
Chiara Magnani
, Silvan Brunn
, et al.
·
Research Square
PDF
Co-editing of NKG2A and FAS increases long-term cytotoxic capacity and persistence of CAR NK cells
2026
·
Mietz, Juliane
, Egli, Lukas
, et al.
·
Zurich Open Repository and Archive (University of Zurich)
CD19 CAR T Cells Drive a Remodeling of the Immune Microenvironment Associated with T-Cell Dysfunction in Acute Lymphoblastic Leukemia
2024
·
Marianna Ponzo
, Lorenzo Drufuca
, et al.
·
Blood
PDF
Anti-CD117 CAR T cells incorporating a safety switch eradicate human acute myeloid leukemia and hematopoietic stem cells
2023
·
Chiara F. Magnani
, Renier Myburgh
, et al.
·
Molecular Therapy — Oncolytics
PDF
P1361: Sleeping Beauty Platform for Engineering Car-cik Cells Toward a Multi-targeting Strategy in B-all
2023
·
Alex Moretti
, Beatrice Landoni
, et al.
·
HemaSphere
Figure S3 from Combination of PPARγ Agonist Pioglitazone and Trabectedin Induce Adipocyte Differentiation to Overcome Trabectedin Resistance in Myxoid Liposarcomas
2023
·
Roberta Frapolli
, Ezia Bello
, et al.
Figure S2 from Combination of PPARγ Agonist Pioglitazone and Trabectedin Induce Adipocyte Differentiation to Overcome Trabectedin Resistance in Myxoid Liposarcomas
2023
·
Roberta Frapolli
, Ezia Bello
, et al.
Figure S1 from Combination of PPARγ Agonist Pioglitazone and Trabectedin Induce Adipocyte Differentiation to Overcome Trabectedin Resistance in Myxoid Liposarcomas
2023
·
Roberta Frapolli
, Ezia Bello
, et al.
Figure S2 from Combination of PPARγ Agonist Pioglitazone and Trabectedin Induce Adipocyte Differentiation to Overcome Trabectedin Resistance in Myxoid Liposarcomas
2023
·
Roberta Frapolli
, Ezia Bello
, et al.
PDF
Figure S3 from Combination of PPARγ Agonist Pioglitazone and Trabectedin Induce Adipocyte Differentiation to Overcome Trabectedin Resistance in Myxoid Liposarcomas
2023
·
Roberta Frapolli
, Ezia Bello
, et al.
PDF
Figure S1 from Combination of PPARγ Agonist Pioglitazone and Trabectedin Induce Adipocyte Differentiation to Overcome Trabectedin Resistance in Myxoid Liposarcomas
2023
·
Roberta Frapolli
, Ezia Bello
, et al.
PDF
Show more works
View as search
Works count:
36
Citation count:
338
H-index:
8
I10-index:
6
Year
Topic
Type